A ruling by US District Judge Ursula Ungaro in Florida said the FDA has the authority to regulate clinics that market unapproved procedures using stem cells derived from a patient's own fat. Researcher Leigh Turner of the University of Minnesota's Center for Bioethics said hundreds of clinics offer similar procedures and could be subject to FDA enforcement action.
Expert: Ruling could affect hundreds of stem cell clinics
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.